Epidermolytic HyperkeratosisSymptoms, Doctors, Treatments, Advances & More
Epidermolytic Hyperkeratosis Overview
Learn About Epidermolytic Hyperkeratosis
Epidermolytic hyperkeratosis is a skin disorder that is present at birth. Affected babies may have very red skin (erythroderma) and severe blisters. Because newborns with this disorder are missing the protection provided by normal skin, they are at risk of becoming dehydrated and developing infections in the skin or throughout the body (sepsis).
Mutations in the KRT1 or KRT10 genes are responsible for epidermolytic hyperkeratosis. These genes provide instructions for making proteins called keratin 1 and keratin 10, which are found in cells called keratinocytes in the outer layer of the skin (the epidermis). The tough, fibrous keratin proteins attach to each other and form fibers called intermediate filaments, which form networks and provide strength and resiliency to the epidermis.
Epidermolytic hyperkeratosis affects approximately 1 in 200,000 to 300,000 people worldwide.
Epidermolytic hyperkeratosis can have different inheritance patterns. About half of the cases of this condition result from new mutations in the KRT1 or KRT10 gene and occur in people with no history of the disorder in their family.
Liat Samuelov practices practicing medicine in Tel Aviv, Israel. Ms. Samuelov is rated as an Elite expert by MediFind in the treatment of Epidermolytic Hyperkeratosis. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Palmoplantar Keratoderma, Epidermolytic Hyperkeratosis, Acrokeratoelastoidosis of Costa, and Pachyonychia Congenita.
Toshifumi Nomura practices practicing medicine in Tsukuba, Japan. Nomura is rated as an Elite expert by MediFind in the treatment of Epidermolytic Hyperkeratosis. They are also highly rated in 26 other conditions, according to our data. Their clinical expertise encompasses Palmoplantar Keratoderma, Acrokeratoelastoidosis of Costa, Epidermolytic Hyperkeratosis, and Nonbullous Congenital Ichthyosiform Erythroderma.
Takuya Takeichi practices practicing medicine in Nagoya, Japan. Mr. Takeichi is rated as an Elite expert by MediFind in the treatment of Epidermolytic Hyperkeratosis. He is also highly rated in 53 other conditions, according to our data. His clinical expertise encompasses Nonbullous Congenital Ichthyosiform Erythroderma, Lamellar Ichthyosis, Epidermolytic Hyperkeratosis, Pityriasis Rubra Pilaris, and Tissue Biopsy.
Published Date: November 01, 2011
Published By: National Institutes of Health